Indexed logomarkindexed.vc

BrightEdge Fund

Corporate VC

BrightEdge is the innovation, impact investment, and venture capital arm of the American Cancer Society. Invests in for-profit companies developing novel cancer-focused therapies and technologies. Deployed $43 million in 21 cancer-focused companies.

Atlanta, United States · 7+ investments · 6 portfolio companies

Early Stage
Biotech
Healthcare
Headquarters
Atlanta, United States
Website
acsbrightedge.org
Portfolio Companies
6
Total Investments
7
Last Investment
May 2025
Geographic Focus
United States

Investment Thesis

BrightEdge operates at the intersection of investment and innovation to define and catalyze scientific, social, and sustainable impact across the continuum of cancer care, leveraging ACS expertise to invest in oncology startups.

BrightEdge Fund is a Corporate VC firm based in Atlanta, United States. It has made 7 investments, including Catena Biosciences, Thatch and Auron Therapeutics. Focus areas include Biotech and Healthcare.

Portfolio6

Co-investors24

Sign up to view co-investors

24 co-investors across 24 shared portfolio companies — who they back alongside, and how often they lead.

Venture Capital ×21 · Hedge Fund ×1 · Corporate VC ×1 · 26 shared rounds

Investment History

Sign up to view investment history

Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.

Your firm? Embed this profile

Add the live badge to your site — it stays current as your portfolio data updates.

BrightEdge Fund on Indexed.vc
<a href="https://indexed.vc/investors/brightedge-fund"><img src="https://indexed.vc/api/badge/investor/brightedge-fund" alt="BrightEdge Fund on Indexed.vc" width="260" height="76" /></a>